News
Alongside Novartis, BioGeneration Ventures (BGV) has also come onboard as a new investor, with general partner Oskar Slotboom joining the biotech's board. In a new pharmaphorum podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback